Cynapsedx
http://cynapsedx.com/technology/ WebCynapseDx is currently conducting a trial to demonstrate that our assays can save money and resources for any health service by cost effectively identifying patients mis-diagnosed with Parkinson’s disease. This will secure the funding to complete the development of all 3 assays for ß-amyloid, α-synuclein and phospho-tau. ...
Cynapsedx
Did you know?
WebCynapseDx has incorporated three technical enhancements to allow us to measure the oligomeric and aggregated forms of these biomarker proteins in blood. Immunoconcentration. We use antibody-coated magnetic … Webcynapsedx.com Claim your profile to get in front of buyers, investors, and analysts. Submit Your Analyst Briefing Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more. Overview & Products Financials People Alternatives & Competitors Customers CynapseDx has not claimed their Profile.
http://cynapsedx.com/about-us Webwww.cynapsedx.com/about-us Formerly Known As Cell Cap Technologies Ownership Status Acquired/Merged (Operating Subsidiary) Financing Status Formerly VC-backed …
WebCynapseDx Connect to CRM Summary Financials People Technology Signals & News Similar Companies Highlights Employee Profiles 2 About CynapseDx has 2 current employee profiles, including Co-Founder & CTO Christopher Stanley. Contacts We're working on getting contact data for CynapseDx Find more contact data in Search! Get … http://cynapsedx.com/novel-aggregated-biomarker
WebCynapseDx's key executives include Damian Bond and 2 others. Damian Bond Chief Executive Peter Foster Chairman Christopher Stanley Chief Technology Officer Source: cynapsedx.com Report incorrect company information Key Executive Tracking Receive notifications of key executive changes Get started Executives of similar companies Vivid …
WebCynapseDx (formerly CellCap Technologies) is a company that develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people … sabeeha merchant ucla biochemistryWebCynapseDx (formerly CellCap Technologies) is a company that develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from neurodegenerative diseases. View company Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via … is heating wax a chemical changehttp://email.cynapsedx.com/partnering sabeeha s. merchantWebCynapseDx is the new name for CellCap Technologies. The new name better reflects our focus on development of blood tests for Parkinson's and Alzheimer's diseases. It builds on the… Chief... is heatmor a legendaryWebJun 8, 2024 · CynapseDx develops products to isolate proteins or cells from whole blood. Its primary focus is neurodegenerative diseases, such as Parkinson’s or Alzheimer’s Disease. is heatpal any goodWebCynapseDx is currently conducting a trial to demonstrate that our assays can save money and resources for any health service by cost effectively identifying patients mis … sabeel wave of prayerWebCYNAPSEDX is part of PHARMAKURE LIMITED. FOR MORE INFORMATION PLEASE VISIT WWW.PHARMAKURE.COM Manx MSA TV review. Manx TV review of ManxMSA … is heatmap one or two words